Outset Medical Inc. Market Research Report
Company Overview
Name: Outset Medical, Inc.
Mission Statement: Not explicitly stated in the provided data. However, it can be inferred that Outset Medical is committed to transforming the dialysis experience by providing innovative home dialysis solutions that enhance patient autonomy and reduce the complexity of dialysis treatment.
Founded: 2013
Founders: Information not provided.
Key People:
- Leslie Trigg, Chair and CEO
- Michael Baker, Founder and former CEO
- Michael Aragon, MD, Chief Medical Officer
Headquarters: San Jose, California, USA
Number of Employees: No information is available.
Revenue: Outset Medical ranked 33rd on Deloitte's 2022 Technology Fast 500, indicating significant revenue growth, though specific figures are not provided.
What is the Company Known For: Outset Medical is known for the Tablo® Hemodialysis System, a state-of-the-art dialysis machine that can be used in both home and hospital settings, offering a more user-friendly and efficient dialysis experience.
Products
Tablo® Hemodialysis System
- High-Level Description: The Tablo system is a compact hemodialysis machine designed for use at home, in clinics, nursing homes, hospitals, and intensive care units. It represents a significant advancement in dialysis technology, aimed at simplifying treatment and giving patients more control over their health.
- Key Features:
- FDA-cleared for use at home and in medical facilities.
- Utilizes a touchscreen interface with on-screen animations and step-by-step instructions.
- Connects to a water source like a kitchen or bathroom sink to purify tap water for dialysis.
- Facilitates easy setup with a single-use cartridge for bloodlines.
- Compact, patient-friendly design.
- Features wireless communication for cloud connectivity, enabling remote machine monitoring and data reporting.
- Suitable for a variety of treatment types, including Intermittent Hemodialysis (IHD) and Sustained Low-Efficiency Dialysis (SLED/SLEDD).
Additional Products and Services
- TabloCart™: An accessory for the Tablo system designed to enhance mobility and include additional features like storage drawers and water prefiltration.
No further product details were provided.
Recent Developments
- Leadership: Leslie Trigg has been leading Outset Medical as the Chair and CEO, bringing a fresh perspective and driving the company's strategic growth.
- Innovation: Outset Medical's Tablo system has received significant recognition, including a landmark TPNIES approval from CMS for its innovative contribution to dialysis technology.
- Regulatory Milestones: The system has secured multiple FDA clearances, and the company recently navigated additional FDA reviews to clear the newest modifications.
- Partnerships and Manufacturing: Outset has expanded its manufacturing capabilities with facilities in Tijuana, Mexico, through partnerships with TACNA and another local manufacturer for Tablo cartridges.
- Financial Performance: Outset increased its revenue guidance for 2022, expecting 8-10% growth over 2021, reflecting strong market acceptance and expansion despite the challenges of the COVID-19 pandemic.
- Industry Recognition: The company ranks among the fastest-growing in medtech and globally, as indicated by its high placement on Deloitte’s Technology Fast 500 list.
- Technological Growth: Continuous updates and enhancements to the Tablo system, including cloud-based training tools developed during the COVID-19 pandemic, have positioned the company well for future growth and adoption.
No additional new products, features, or partnerships were mentioned.
Please note: The above fields without direct information have been labeled as "No information is available," as required.
